A recent study highlights the diagnostic challenges posed by poorly differentiated lung adenocarcinomas that express both ALK and CD30, which can mimic ALK-positive anaplastic large-cell lymphoma. This finding underscores the need for careful differential diagnosis in clinical settings.
poorly differentiated lung adenocarcinomas with concurrent alk and cd30 expression a diagnostic pitfall mimicking alk positive anaplastic large cell lymphoma
Original title: “Poorly differentiated lung adenocarcinomas with concurrent ALK and CD30 expression: a diagnostic pitfall mimicking ALK-positive anaplastic large-cell lymphoma.”